Multiple phenotypes and epigenetic profiles in a three-generation family history with GATA2 deficiency.
Damia Romero-Moya, Joan Pera, Oskar Marin-Bejar, Eric Torralba-Sales, Laura Murillo-Sanjuán, Cristina Diaz-de-Heredia, Julia Montoro, Javier Rodríguez-Ubreva, Alessandro Liquori, José Cervera and 3 more
Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Oskar Marin-BejarRegenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.
Eric Torralba-SalesRegenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.
Laura Murillo-SanjuánPediatric Hematology and Oncology Division, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Cristina Diaz-de-HerediaPediatric Hematology and Oncology Division, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona, Spain.
Julia MontoroDepartment of Hematology, Vall d'Hebron Hospital Universitari, Barcelona, Spain.
Javier Rodríguez-UbrevaEpigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4707-4536
Alessandro LiquoriHematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
José CerveraHematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Albert CatalàDepartment of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Deu, Barcelona, Spain.
Alessandra Giorgetti *Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain. agiorgetti@idibell.cat.ORCID http://orcid.org/0000-0001-5803-3567
Funding
European Hematology Association (EHA) KOG-202109-01162José Carreras Leukämie-Stiftung (Deutsche José Carreras Leukämie-Stiftung) DJCLS 13R/2022Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PID2020-15591RB-100Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) AC23_2/00040Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) FORT23/00032
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Multiple phenotypes and epigenetic profiles in a three-generation family history with GATA2 deficiency. · full record | OpenQuestion